These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35116712)

  • 1. Cervical carcinoma high-expressed long non-coding RNA 1 promotes papillary thyroid carcinoma cell proliferation and invasion.
    Shi P; Liu Y; Zhang M; Yang J; Jing S; Yang D; Liu F; Wu Y; Shi H; Geng C
    Transl Cancer Res; 2021 Sep; 10(9):4158-4168. PubMed ID: 35116712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma.
    Zhang Z; Li SY; Zhang LB
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA CCHE1 increased proliferation, metastasis and invasion of non-small lung cancer cells and predicted poor survival in non-small lung cancer patients.
    Liao Y; Cheng S; Xiang J; Luo C
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1686-1692. PubMed ID: 29630113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of lncRNA CCHE1 inhibits cell proliferation, migration and invasion by suppressing MEK/ERK/c-MYC pathway in nasopharyngeal carcinoma.
    Meng XJ; Wang JC; Wang AQ; Xia WQ
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8880-8888. PubMed ID: 32964977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of long non-coding RNA CCHE1 in colorectal carcinoma: correlations with clinicopathological features and ERK/COX-2 pathway.
    Gaballah HH; Gaber RA; Elrashidy MA; Elshahat DA; Hablus MA; Ebeid AM
    Mol Biol Rep; 2019 Feb; 46(1):657-667. PubMed ID: 30484108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
    Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
    Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA-CCHE1 is involved in migration and invasion but not in proliferation of pancreatic adenocarcinoma cells possibly by interacting with ROCK1.
    Jin X; Ye L; Lin M; Gu B; Wang J; He Y; Li W
    Oncol Lett; 2019 Aug; 18(2):1218-1224. PubMed ID: 31423182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA CCHE1 participates in postoperative distant recurrence but not local recurrence of osteosarcoma possibly by interacting with ROCK1.
    Zhang Z; Yu T; Geng W
    BMC Musculoskelet Disord; 2020 Jul; 21(1):462. PubMed ID: 32660450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
    Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of long noncoding RNA SLC26A4-AS1 inhibits the epithelial-mesenchymal transition via the MAPK pathway in papillary thyroid carcinoma.
    Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J
    J Cell Physiol; 2020 Mar; 235(3):2403-2413. PubMed ID: 31556116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
    Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
    Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
    Huang F; Zhang Q; Chen W; Zhang H; Lu G; Chen J; Qiu C
    J Cell Biochem; 2019 Jun; 120(6):10380-10390. PubMed ID: 30609134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding ROR promotes the progression of papillary thyroid carcinoma through regulation of the TESC/ALDH1A1/TUBB3/PTEN axis.
    Fan Y; Fan X; Yan H; Liu Z; Wang X; Yuan Q; Xie J; Lu X; Yang Y
    Cell Death Dis; 2022 Feb; 13(2):157. PubMed ID: 35173149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA CCHE1 in the proliferation and apoptosis of gastric cancer cells.
    Xu G; Zhang Y; Li N; Zhang JB; Xu R
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2631-2637. PubMed ID: 29771412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of long non-coding RNA NR_036575.1 contributes to the proliferation and migration of papillary thyroid cancer.
    Sun W; Lan X; Wang Z; Dong W; He L; Zhang T; Zhang H
    Med Oncol; 2016 Sep; 33(9):102. PubMed ID: 27510368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA FALEC promotes proliferation, migration, and invasion of PTC cells through regulating Wnt/β-catenin signaling pathway.
    Xiao X; Li L; Cui JC; Wang Y
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4361-4367. PubMed ID: 32373973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA NORAD promotes thyroid carcinoma progression by targeting miR-451.
    Shi L; Cong YZ; Wang ZJ
    Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6187-6195. PubMed ID: 34730199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA CCHE1 indicates a poor prognosis of hepatocellular carcinoma and promotes carcinogenesis via activation of the ERK/MAPK pathway.
    Peng W; Fan H
    Biomed Pharmacother; 2016 Oct; 83():450-455. PubMed ID: 27427851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-142-3P suppresses the progression of papillary thyroid carcinoma by targeting FN1 and inactivating FAK/ERK/PI3K signaling.
    Jiang Y; Liu Y; Zhang Y; Ouyang J; Feng Y; Li S; Wang J; Zhang C; Tan L; Zhong J; Zou L
    Cell Signal; 2023 Sep; 109():110792. PubMed ID: 37406787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Long Non-Coding RNA ENST00000489676 Influences Papillary Thyroid Cancer Cell Proliferation and Invasion through Regulating MiR-922.
    Wang W; Xia S; Zhan W
    J Cancer; 2019; 10(22):5434-5446. PubMed ID: 31632488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.